186 related articles for article (PubMed ID: 20371706)
1. Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness.
Wang M; Cooper PR; Jiang M; Zhao H; Hui Y; Yao Y; Tate JC; Damera G; Lawson JA; Jester WF; Haczku A; Panettieri RA; FitzGerald GA
J Pharmacol Exp Ther; 2010 Jul; 334(1):63-8. PubMed ID: 20371706
[TBL] [Abstract][Full Text] [Related]
2. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
[TBL] [Abstract][Full Text] [Related]
3. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
[TBL] [Abstract][Full Text] [Related]
4. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.
Wang M; Lee E; Song W; Ricciotti E; Rader DJ; Lawson JA; Puré E; FitzGerald GA
Circulation; 2008 Mar; 117(10):1302-9. PubMed ID: 18285567
[TBL] [Abstract][Full Text] [Related]
5. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.
Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
FASEB J; 2006 Nov; 20(13):2387-9. PubMed ID: 17023389
[TBL] [Abstract][Full Text] [Related]
6. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile.
Boulet L; Ouellet M; Bateman KP; Ethier D; Percival MD; Riendeau D; Mancini JA; Méthot N
J Biol Chem; 2004 May; 279(22):23229-37. PubMed ID: 15016822
[TBL] [Abstract][Full Text] [Related]
7. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Pollastro F; Northoff H; Werz O
Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
[TBL] [Abstract][Full Text] [Related]
8. Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury.
Wang M; Ihida-Stansbury K; Kothapalli D; Tamby MC; Yu Z; Chen L; Grant G; Cheng Y; Lawson JA; Assoian RK; Jones PL; Fitzgerald GA
Circulation; 2011 Feb; 123(6):631-9. PubMed ID: 21282500
[TBL] [Abstract][Full Text] [Related]
9. Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction.
Degousee N; Fazel S; Angoulvant D; Stefanski E; Pawelzik SC; Korotkova M; Arab S; Liu P; Lindsay TF; Zhuo S; Butany J; Li RK; Audoly L; Schmidt R; Angioni C; Geisslinger G; Jakobsson PJ; Rubin BB
Circulation; 2008 Apr; 117(13):1701-10. PubMed ID: 18347209
[TBL] [Abstract][Full Text] [Related]
10. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway.
Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
J Biol Chem; 2007 Feb; 282(8):5356-66. PubMed ID: 17186945
[TBL] [Abstract][Full Text] [Related]
11. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
12. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation.
Lundequist A; Nallamshetty SN; Xing W; Feng C; Laidlaw TM; Uematsu S; Akira S; Boyce JA
J Immunol; 2010 Jan; 184(1):433-41. PubMed ID: 20028661
[TBL] [Abstract][Full Text] [Related]
14. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1.
Guay J; Bateman K; Gordon R; Mancini J; Riendeau D
J Biol Chem; 2004 Jun; 279(23):24866-72. PubMed ID: 15044444
[TBL] [Abstract][Full Text] [Related]
15. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Wang M; Song WL; Cheng Y; Fitzgerald GA
J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
[TBL] [Abstract][Full Text] [Related]
16. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model.
Claveau D; Sirinyan M; Guay J; Gordon R; Chan CC; Bureau Y; Riendeau D; Mancini JA
J Immunol; 2003 May; 170(9):4738-44. PubMed ID: 12707354
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 produced by microsomal prostaglandin E synthase-1 regulates the onset and the maintenance of wakefulness.
Takemiya T
Neurochem Int; 2011 Nov; 59(6):922-4. PubMed ID: 21784115
[TBL] [Abstract][Full Text] [Related]
18. Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.
Sasaki Y; Kamei D; Ishikawa Y; Ishii T; Uematsu S; Akira S; Murakami M; Hara S
Oncogene; 2012 Jun; 31(24):2943-52. PubMed ID: 21986945
[TBL] [Abstract][Full Text] [Related]
19. Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction.
Jia Z; Wang H; Yang T
Hypertension; 2012 Jan; 59(1):122-8. PubMed ID: 22106404
[TBL] [Abstract][Full Text] [Related]
20. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
